Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cyclo Therapeutics Inc
CYTHCurrent price
0.72 USD
0 USD (0.00%)
Last closed
0.71 USD
Company
www.cyclotherapeutics.com
ISIN
US23254X2018
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
21 206 344 USD
Yield for 12 month
-51.02 %
1Y
3Y
5Y
10Y
15Y
CYTH
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. Address: 6714 NW 16th Street, Gainesville, FL, United States, 32653
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.95 USDP/E ratio
–Dividend Yield
–Current Year
+1 076 405 USD
Last Year
+1 375 760 USD
Current Quarter
+123 104 USD
Last Quarter
+202 450 USD
Current Year
-2 410 176 USD
Last Year
+1 236 831 USD
Current Quarter
-808 023 USD
Last Quarter
-634 031 USD
Key Figures CYTH
1 year
3 years
5 years
10 years
EBITDA
-21 140 932 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-282.49 %
PEG Ratio
–
Return On Equity TTM
-22663.91 %
Wall Street Target Price
0.95 USD
Revenue TTM
1 132 430 USD
Book Value
-0.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
5.1 %
Dividend Yield
–
Gross Profit TTM
1 225 812 USD
Earnings per share
-0.82 USD
Diluted Eps TTM
-0.82 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CYTH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CYTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
09.12.2020
Dividend Date
09.12.2020
Stock Valuation CYTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
19.8095
Price Sales TTM
18.7264
Enterprise Value EBITDA
-0.4714
Price Book MRQ
59.1038
Financials CYTH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CYTH
For 52 weeks
0.59 USD
2.12 USD
50 Day MA
0.72 USD
Shares Short Prior Month
167 192
200 Day MA
1.21 USD
Short Ratio
3.4
Shares Short
130 451
Short Percent
0.53 %
BeatStart